Portfolio Update:TytoCare is Ranked 22 as One of the 50 Most Promising Israeli Startups
TytoCare’s equipment enables various medical tests to be carried out at home and is proving popular in the U.S. and U.K.
Israeli readers need no introduction to TytoCare: The product it developed is available to clients of local healthcare providers and its use has only gone up over the past year. Like many companies in the telemedicine field, Tyto experienced a surge in demand during the pandemic. The solution it offers, however, isn’t derived from any specific disease but instead from the continuously growing burden on healthcare systems around the world due to aging populations.
Even though the telemedicine industry has taken center stage, it is important to note that in order to realize the mind-boggling potential of remote healthcare, the proper equipment is required. A virtual visit to the doctor will be forced to remain in the realm of science fiction unless the hardware and software to enable it exists. That’s where TytoCare comes in.
In the wake of the Covid-19 pandemic, Tyto tripled its sales; and since it operates on a subscription basis, it must be able to show that its technology is consistently being used by both doctors and patients.
Over the past year, Tyto carried out close to 650,000 examinations and is being regularly used by 8,000 physicians. The company is currently in negotiations with one of the biggest technological players in the field, has begun working with some of the largest healthcare providers in the U.S., and has established a significant foothold in the European market too, by collaborating with the UK’s NHS.
- Hagar Ravet(新闻原文